The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 19, 2020

Filed:

Aug. 28, 2015
Applicant:

Ucl Business Plc, London, GB;

Inventors:

Martin Pulé, London, GB;

Shaun Cordoba, London, GB;

Khai Kong, London, GB;

Assignee:

UCL BUSINESS LTD, London, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 35/17 (2015.01); C12N 5/10 (2006.01); C12N 15/13 (2006.01); C12N 15/52 (2006.01); C12N 15/62 (2006.01); A61K 39/00 (2006.01); C07K 14/725 (2006.01); C07K 14/705 (2006.01); C07K 16/28 (2006.01); C12N 5/0783 (2010.01); A61K 31/65 (2006.01); C07K 14/73 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2803 (2013.01); A61K 31/65 (2013.01); A61K 35/17 (2013.01); C07K 14/7051 (2013.01); C07K 14/70514 (2013.01); C12N 5/0636 (2013.01); C07K 2317/622 (2013.01); C07K 2319/80 (2013.01); C12N 2510/00 (2013.01);
Abstract

The present invention provides a chimeric antigen receptor (CAR) signalling system comprising; (i) a receptor component comprising an antigen binding domain, a transmembrane domain and a first binding domain; and (ii) an intracellular signalling component comprising a signalling domain and a second binding domain which specifically binds the first binding domain of the receptor component; wherein, binding of the first and second binding domains is disrupted by the presence of an agent, such that in the absence of the agent the receptor component and the signalling component heterodimerize and binding of the antigen binding domain to antigen results in signalling through the signalling domain, whereas in the presence of the agent the receptor component and the signalling component do not heterodimerize and binding of the antigen binding domain to antigen does not result in signalling through the signalling domain.


Find Patent Forward Citations

Quick Actions:

Pulé, Martin. (2020). Signalling system (U.S. Patent No. 10654927). U.S. Patent and Trademark Office. https://idiyas.com/patent/badge/10654927

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Loading…